qCT-Lung

Qure.ai
qCT-Lung aids lung cancer screening programs and facilitates opportunistic screening using AI. It provides pre-read assistance to clinicians by detecting lung nodules & emphysema.
qureai-qct-lung.png
qureai-qct-lung_1.jpg
qureai-qct-lung.png
qureai-qct-lung_1.jpg
Information source: Vendor
Last updated: March 25, 2023

General Information

General
Product name qCT-Lung
Company Qure.ai
Subspeciality Chest
Modality CT
Disease targeted Lung cancer, emphysema
Key-features Lung nodule detection, emphysema detection
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population Chest CTs for adults (age >= 18 years)
Input Non-contrast chest CTs, consistently spaced axial slices, soft reconstruction kernel, maximum slice thickness of 6 mm, minimum of 40 axial slices
Input format DICOM
Output Image annotation overlay
Output format DICOM secondary capture, PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes

Regulatory

Certification
CE
Certified, Class IIb , MDR
FDA No or not yet
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since 08-2021
Distribution channels deepcOS
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers